BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Abemaciclib
Related studies linked through entity extraction aliases.
Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt
- Status
- COMPLETED
- Phase
- PHASE4
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Status
- RECRUITING
- Phase
- PHASE3
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Using Tumor Models to Determine Treatments
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
- Status
- RECRUITING
- Phase
- N/A
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2